Benjamin Burnett

Stock Analyst at Stifel

(0.65)
# 2581
Out of 5,441 analysts
95
Total ratings
Success rate
Average return
24 Stocks
Name Action PT Current % Upside Ratings Updated
RVMD Revolution Medicines
Maintains: Buy
78 64
34.71 84.38% 5 Apr 1, 2025
FATE Fate Therapeutics
Maintains: Hold
5 3
0.94 219.15% 3 Mar 6, 2025
CRSP CRISPR Therapeutics
Maintains: Hold
53 49
55.44 -11.62% 6 Feb 13, 2025
IRON Disc Medicine
Maintains: Strong Buy
90 94
58.61 60.38% 7 Jan 24, 2025
RPTX Repare Therapeutics
Maintains: Buy
9 4
1.54 159.74% 5 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
83 122
69.11 76.53% 5 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
17.16 302.1% 2 Sep 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
63 68
22.84 197.72% 7 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
1.74 474.71% 3 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 5
1.03 346.6% 5 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
120 58
10.4 452.88% 4 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 3
2.65 -2.26% 4 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
11 11
10.25 0% 2 Feb 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
83 59
58.7 0.51% 6 Nov 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25
1.97 1169.04% 11 Sep 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
33 175
n/a n/a 4 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
9 10
9.1 0% 2 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
280 18
3.49 415.76% 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Aug 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
5 1
n/a n/a 1 Apr 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
690 780
4.36 17789.91% 2 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
330 360
22.48 1501.42% 2 Jun 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
16
n/a n/a 1 Jan 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
1880 1400
4.97 28069.01% 3 Mar 27, 2020